AI & ChatGPT searches , social queries for PRASUGREL
Search references for PRASUGREL. Phrases containing PRASUGREL
See searches and references containing PRASUGREL!
Search references for PRASUGREL. Phrases containing PRASUGREL
See searches and references containing PRASUGREL!PRASUGREL
Medication used to prevent formation of blood clots
Prasugrel, sold under the brand names Effient and Efient, is a medication used to prevent formation of blood clots. It is a platelet inhibitor and an
Prasugrel
Coronary medication
revascularisation (restoration of blood flow). Like the thienopyridines prasugrel, clopidogrel and ticlopidine, ticagrelor blocks adenosine diphosphate
Ticagrelor
Antiplatelet medication
esomeprazole, but pantoprazole appears to be safe. The newer antiplatelet agent prasugrel has minimal interaction with (es)omeprazole, hence might be a better antiplatelet
Clopidogrel
Drug class of antiplatelet agents
adverse effects it is not much used today. Ticlopidine, clopidogrel and prasugrel (Efient) are all thienopyridines that cause irreversible inhibition of
Adenosine diphosphate receptor inhibitor
Adenosine_diphosphate_receptor_inhibitor
Protein-coding gene in the species Homo sapiens
functions and microglial neuroprotection. The drugs clopidogrel (Plavix), prasugrel (Efient, Effient), ticagrelor (Brilinta), and cangrelor (Kengreal) bind
P2Y12
Interruption of cardiac blood supply
myocardial infarction by at least 50%. P2Y12 inhibitors such as clopidogrel, prasugrel and ticagrelor are given concurrently, also as a loading dose, with the
Myocardial_infarction
Japanese pharmaceutical company
Vanflyta (quizartinib) Zelboraf (vemurafenib) Cardiovascular Effient (prasugrel) (co-marketed with Eli Lilly and Company; also sold as Efient) Lixiana/Savaysa
Daiichi_Sankyo
Class of pharmaceuticals
combination of aspirin plus an ADP/P2Y inhibitor (such as clopidogrel, prasugrel, ticagrelor, or another) is used to obtain greater effectiveness than
Antiplatelet_drug
Class of chemical compounds
thrombosis and strokes. Drugs in this class include: clopidogrel (Plavix), prasugrel (Effient), and ticlopidine (Ticlid). Tinoridine was actually a predecessor
Thienopyridine
Pharmaceutical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Sipagladenant
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Adenosine
Bitter alkaloid of the cacao plant
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Theobromine
Resinous mixture produced by honey bees
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Propolis
Central nervous system stimulant
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Caffeine
Sulfur-containing aromatic compound
D; Rosi; Debernardi; Bertho; Mansuy (2012). "Metabolic Activation of Prasugrel: Nature of the Two Competitive Pathways Resulting in the Opening of Its
Thiophene
Medication
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Allopurinol
Organosulfur compounds of the form R–SC(=O)–R′
bioactivation of the antithrombotic prodrugs ticlopidine, clopidogrel, and prasugrel. As posited in a "Thioester World", thioesters are possible precursors
Thioester
Medication for parasite infestations
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Ivermectin
Process of formation of blood clots
include aspirin, dipyridamole, ticlopidine, clopidogrel, ticagrelor and prasugrel; the parenteral glycoprotein IIb/IIIa inhibitors are used during angioplasty
Coagulation
Chemotherapy and immunosuppressant medication
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Methotrexate
Nonsteroidal anti-inflammatory drug
aspirin is combined with an ADP receptor inhibitor, such as clopidogrel, prasugrel, or ticagrelor to prevent blood clots. This is called dual antiplatelet
Aspirin
Chemical compound of RNA
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Uracil
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Hypoxanthine
Type of drugs
triad of asthma, rhinitis and nasal polyps P2Y12 Inhibitors Clopidogrel Prasugrel Ticagrelor Block P2Y12 receptors on platelets → prevent platelet activation
Commonly_prescribed_drugs
Medical condition
Sunitinib Platelet aggregation inhibitors (ticlopidine, clopidogrel, and prasugrel) Immunosuppressants (ciclosporin, mitomycin, tacrolimus/FK506, interferon-α)
Thrombotic thrombocytopenic purpura
Thrombotic_thrombocytopenic_purpura
Species of flowering plant
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Valerian_(herb)
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Phytic_acid
Heterocyclic aromatic organic compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Purine
Drug used to treat respiratory diseases
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Theophylline
(INN) pranolium chloride (INN) pranoprofen (INN) Prantal prasterone (INN) prasugrel (INN) Pravachol pravadoline (INN) pravastatin (INN) Pravigard Pac praxadine
List_of_drugs:_Pj–Pra
Aromatic compound (C4H4N2)
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Pyrimidine
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Paraxanthine
Biological molecules constituting nucleic acids
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Nucleotide
Carbocyclic sugar
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Inositol
Drug classification – antithrombotic agents
Tirofiban B01AC18 Triflusal B01AC19 Beraprost B01AC21 Treprostinil B01AC22 Prasugrel B01AC23 Cilostazol B01AC24 Ticagrelor B01AC25 Cangrelor B01AC26 Vorapaxar
ATC_code_B01
Medical diagnostic method
results in platelet aggregation. Antiplatelet drugs like clopidogrel and prasugrel irreversibly inhibit the ADP receptor P2Y12, leading to a decreased ADP-induced
Multiple electrode aggregometry
Multiple_electrode_aggregometry
Organic compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Uric_acid
Component of blood aiding in coagulation
are used to prevent thrombus formation. Aspirin Cilostazol Clopidogrel Prasugrel Ticagrelor Ticlopidine Abciximab Eptifibatide Tirofiban Argatroban Desmopressin
Platelet
Dysfunction of the heart muscles due to insufficient blood flow
treatment with aspirin, a second platelet inhibitor such as clopidogrel, prasugrel or ticagrelor, and heparin (usually a low-molecular weight heparin), with
Acute_coronary_syndrome
Organosulfur compound of the form R–SOH
drugs, such as omeprazole, esomeprazole, ticlopidine, clopidogrel, and prasugrel is proposed to involve sulfenic acid intermediates. Oxidation of cysteine
Sulfenic_acid
Medical stent implanted into coronary arteries
with another anti-platelet agent, typically clopidogrel, ticagrelor or prasugrel, depending on the situation. Maintenance dual anti-platelet use is usually
Coronary_stent
Class of drugs
, warfarin) and antiplatelet agents (e.g., clopidogrel, ticlopidine, prasugrel, ticagrelor, and/or aspirin) should not be altered before dental procedures
Anticoagulant
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Guanosine_triphosphate
pH indicator that turns pink in basic solution
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Phenolphthalein
Chemical compound of DNA and RNA
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Guanine
Codrug of amphetamine and theophylline
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Fenethylline
Chemical compound in nucleic acids
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Cytosine
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Cinnamaldehyde
Chemical compound
studies assessing cangrelor administration in conjunction with either prasugrel or ticagrelor. Cangrelor been approved for adults undergoing percutaneous
Cangrelor
Finerenone Spironolactone Abciximab Aspirin Cangrelor Clopidogrel Eptifibatide Prasugrel Ticagrelor Tirofiban Apixaban Bivalirudin Dabigatran Edoxaban Enoxaparin
List of cardiac pharmaceutical agents
List_of_cardiac_pharmaceutical_agents
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Inosinic_acid
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Quercetin
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Adenosine_monophosphate
Medical intervention
approved for use in acute coronary syndromes, clopidogrel, ticagrelor and prasugrel; all reduce platelet aggregation by inhibiting the P2Y12 receptor, a type
Management of acute coronary syndrome
Management_of_acute_coronary_syndrome
Family of cell membrane receptors in almost all tissues
one's behavior. Inhibitors of purinergic receptors include clopidogrel, prasugrel and ticlopidine, as well as ticagrelor. All of these are antiplatelet
Purinergic_receptor
Chemical linkage of norephedrine and theophylline
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Cafedrine
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
8-Bromotheophylline
Any of several glycosylamines comprising a nucleobase and a sugar molecule
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Nucleoside
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Xanthine
Bronchiodilator
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Diprophylline
Drug used for treatment of asthma
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Theophylline/ephedra/hydroxyzine
Theophylline/ephedra/hydroxyzine
Class of drugs
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Adenosine_receptor_agonist
Chemicals that inhibit the use of a metabolite
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Pyrimidine_analogue
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
UK-432,097
Protein-coding gene in the species Homo sapiens
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
P2RY14
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
8-Cyclopentyl-1,3-dimethylxanthine
8-Cyclopentyl-1,3-dimethylxanthine
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Caffeic_acid
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Cilostazol
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Pentoxifylline
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Kaempferol
Medical drug
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Suramin
Group of simple sugar and carbohydrate compounds
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Ribose
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Adenosine_diphosphate
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Adenosinergic
Chemical in plants
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Apigenin
Active ingredient in fermented drinks
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Alcohol_(drug)
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Theacrine
of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans". The Journal of Clinical Pharmacology. 50 (2): 126–142. doi:10
Thiolactone
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Pemetrexed
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Phenol_red
Pharmaceutical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
YZG-331
Chemical compound
"Impact of Intravenous Lysine Acetylsalicylate Versus Oral Aspirin on Prasugrel-Inhibited Platelets: Results of a Prospective, Randomized, Crossover Study
Lysine_acetylsalicylate
Selective adenosine A2A receptor antagonist
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
MSX-2
Biological communication between cells involving purine nucleosides and their receptors
of methotrexate. Anti-platelet drugs Many anti-platelet drugs such as Prasugrel, Ticagrelor, and Ticlopidine are adenosine diphosphate (ADP) receptor
Purinergic_signalling
One of the five major nucleosides in nucleic acids
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Uridine
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Cytidine
Adenosine A2A receptor antagonist and MAO-B inhibitor
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
3-Chlorostyrylcaffeine
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Aminophylline
Anticoagulant drug
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Dipyridamole
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Myricetin
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
5′-(N-Ethylcarboxamido)adenosine
5′-(N-Ethylcarboxamido)adenosine
Selective adenosine A2A receptor antagonist used in scientific research
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
MSX-3
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Regadenoson
Combination of theophylline and ephedrine used to treat asthma
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Theophylline/ephedrine
Chemical compound
base, yielded regrelor. Regrelor was developed around the same time as prasugrel and cangrelor. After Inspire Pharmaceuticals initially developed the drug
Regrelor
Chemical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Emodin
Chemical compound, medication to treat gout
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Febuxostat
German university teacher
treated with percutaneous intervention – Understanding the debate on Prasugrel or Ticagrelor". Pharmacology & Therapeutics. 233 108029. doi:10.1016/j
Johann_Bauersachs
Pharmaceutical compound
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Ciforadenant
MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP Transporter
Ectonucleotidase
PRASUGREL
PRASUGREL
PRASUGREL
PRASUGREL
PRASUGREL
PRASUGREL
PRASUGREL
PRASUGREL
PRASUGREL